Barriers to clinical follow-up visits in multiple sclerosis: A nationwide register-based study.

Background: In Denmark, specialized multiple sclerosis (MS) clinics offer free-of-charge treatment to people with MS. However, not all people with MS attend regular clinical follow-up.

Objective: To identify people with MS who do not attend Danish MS clinics and identify barriers to treatment.

Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study.

Background: Clinicians frequently rely on relapse counts, T2 MRI lesion load (T2L) and Expanded Disability Status Scale (EDSS) scores to guide treatment decisions for individuals diagnosed with multiple sclerosis (MS). This study evaluates how these factors, along with age and sex, influence prognosis during treatment with teriflunomide (TFL).

Methods: We conducted a nationwide cohort study using data from the Danish Multiple Sclerosis Registry.

[Is "quality of life" a relevant goal in clinical studies of rehabilitation?].

By consensus and in accordance with the WHO, the relevant outcomes of rehabilitation are "function" and "social participation". Nevertheless, most physicians will agree that improved Quality of Life (QoL) is the ultimate goal of medicine. Although many well-validated health-related QoL instruments are available, these are generally flawed due to considerable redundancy and lack of consistent responsiveness.

Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study.

Cognitive impairment occurs in early multiple sclerosis (MS), may decline over time, and has major impact on social functioning. The objectives of this study were to examine cognitive functioning in newly diagnosed MS, and to follow up over a period of 5 years. The results of the first three yearly re-examinations are reported.